Price target lifted on Cytokinetics
December 31, 2014 at 16:29 PM EST
Roth Capital lifted its price target on Cytokinetics (Nasdaq: CYTK) from $13 to $18 sending the stock price up $1.11 to close at $8.01.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.